Bridgewater Associates’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-19,281
Closed -$716K 823
2024
Q3
$716K Sell
19,281
-20,559
-52% -$767K ﹤0.01% 648
2024
Q2
$1.9M Sell
39,840
-4,698
-11% -$206K 0.01% 544
2024
Q1
$1.7M Sell
44,538
-7,635
-15% -$248K 0.01% 516
2023
Q4
$1.63M Sell
52,173
-5,819
-10% -$209K 0.01% 555
2023
Q3
$2.33M Buy
57,992
+41,949
+261% +$1.96M 0.01% 476
2023
Q2
$843K Sell
16,043
-1,231
-7% -$75K 0.01% 598
2023
Q1
$1.1M Sell
17,274
-39,316
-69% -$2.57M 0.01% 551
2022
Q4
$2.75M Sell
56,590
-19,094
-25% -$1.2M 0.02% 477
2022
Q3
$5.34M Buy
75,684
+194
+0.3% +$16.6K 0.03% 368
2022
Q2
$5.36M Buy
75,490
+6,864
+10% +$442K 0.02% 465
2022
Q1
$5.48M Buy
68,626
+16,534
+32% +$1.23M 0.02% 448
2021
Q4
$4.76M Buy
52,092
+8,763
+20% +$940K 0.03% 310
2021
Q3
$5.57M Sell
43,329
-3,324
-7% -$465K 0.03% 275
2021
Q2
$7.12M Buy
+46,653
New +$6.15M 0.05% 272

Other funds holding STAA

Bridgewater Associates's STAA Position: Q4 2024 in Review

Bridgewater Associates sold out of STAAR Surgical (STAA) in Q4 2024, closing a stake of 19,281 shares — an estimated $716K sold.

Bridgewater Associates first reported a position in STAA in Q2 2021 and held it in 14 quarters. The position peaked at $7.12M in Q2 2021. 212 funds tracked by Wall St. Rank hold STAA as of Q4 2024.

  • Bridgewater Associates reported no remaining STAAR Surgical position as of Q4 2024 after selling out during the quarter.
  • Bridgewater Associates sold 19,281 STAAR Surgical shares in Q4 2024, an estimated $716K.
  • Bridgewater Associates first reported a position in STAAR Surgical in Q2 2021 and held it in 14 quarters.
  • Bridgewater Associates's STAAR Surgical position peaked at $7.12M in Q2 2021.
  • 212 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2024.

Based on Bridgewater Associates's 13F filing for Q4 2024, filed 13 Feb 2025.